CC BY-NC-ND 4.0 · South Asian J Cancer 2015; 04(01): 046-047
DOI: 10.4103/2278-330X.149954
Letters to Editor

Unusual etiology of secondary thyrotoxicosis and its presentation

Vinayak V. Maka
Department of Medical Oncology, M S Ramaiah Medical College, MSRIT Post, Bangalore, Karnataka
,
S. Murali
Department of Medical Oncology, M S Ramaiah Medical College, MSRIT Post, Bangalore, Karnataka
,
Nalini Kilara
Department of Medical Oncology, M S Ramaiah Medical College, MSRIT Post, Bangalore, Karnataka
› Author Affiliations


Publication History

Article published online:
31 December 2020

© 2015. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorder in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
  • 2 McCracken EJ, Johnston PC, Lindsay JR, Mulholland C, McAleer JJ, Black RN. Testicular choriocarcinoma: An unusual case of paraneoplastic thyrotoxicosis. QJM 2012;105:675-7.
  • 3 Oosting SF, de Haas EC, Links TP, de Bruin D, Sluiter WJ, de Jong IJ, et al. Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumours. Ann Oncol 2010;21:104-8.
  • 4 Oppenheimer JH. Thyroid hormone action at the nuclear level. Ann Intern Med 1985;102:374-84.
  • 5 Kellner O, Voigt W, Schneyer U, Dempke W, Schmoll HJ. HCG induced hyperthyreosis in germ cell cancer. Anticancer Res 2000;20:5135-8.
  • 6 Meister LH, Hauck PR, Graf H, Carvalho GA. Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma. Arq Bras Endocrinol Metabol 2005;49:319-22.